ImmunityBio

IBRX · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Total Revenue

$38.3M

Previous year: $7.55M

+407.0%

EPS

-$0.06

Previous year: -$0.08

-25.0%

R&D Expenses

$63.9M

Previous year: $35.2M

+81.3%

SG&A Expenses

$38.7M

Previous year: $41.7M

-7.2%

Net Cash Used in Operating Activities

-$70.4M

Previous year: -$85.1M

Loading...

ImmunityBio

Unlock previous datapoints

Upgrade

ImmunityBio

Unlock previous datapoints

Upgrade

ImmunityBio Revenue by Segment

Revenue by Segment

Product Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$7.59B

P/E Ratio

-19.27

Sector

N/A

Industry

N/A

52-Week High

$11.5

52-Week Low

$1.86

R&D Expenses

$63.9M

SG&A Expenses

$38.7M

Net Cash Used in Operating Activities

-$70.4M

Fair Value Change - Warrant & Derivatives

$29.2M

Interest Expense - Revenue Interest Liability

-$12.3M

Products

Get in Touch

Resources

ImmunityBio

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment

Revenue by Segment

Product Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics